H
Hainv Gao
Researcher at Zhejiang University
Publications - 61
Citations - 5712
Hainv Gao is an academic researcher from Zhejiang University. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 19, co-authored 51 publications receiving 4919 citations.
Papers
More filters
Journal ArticleDOI
Circulating proteomic panels for diagnosis and risk stratification of acute-on-chronic liver failure in patients with viral hepatitis B
Zeyu Sun,Xiaoli Liu,Daxian Wu,Hainv Gao,Jing Jiang,Ying Yang,Jie Wu,Qikang Gao,Jie Wang,Zhengyi Jiang,Youping Xu,Xiao Xu,Lanjuan Li +12 more
TL;DR: Proteomic signatures developed in this study reflected the deficiency of key hematological functions in HBV-ACLF patients, and show potential forHBV- ACLF diagnosis and risk prediction in complementary to current clinical based parameters.
Journal ArticleDOI
Open-label phase I clinical trial of Ad5-EBOV in Africans in China.
Lihua Wu,Zhe Zhang,Hainv Gao,Yu-Hua Li,Li-Hua Hou,Hangping Yao,Shipo Wu,Jian Liu,Ling Wang,You Zhai,Huilin Ou,Meihua Lin,Xiaoxin Wu,Jingjing Liu,Guanjing Lang,Qian Xin,Guolan Wu,Li Luo,Pei Liu,Jianzhong Shentu,Nanping Wu,Jifang Sheng,Yun-Qing Qiu,Wei Chen,Lanjuan Li +24 more
TL;DR: The application of Ad5-EBOV demonstrated safe in Africans in China and a specific GP antibody and T-cell response could occur 14 d after the first immunization, which provides a reliable basis to proceed with trials in Africa.
Journal ArticleDOI
An analysis of microbiota-targeted therapies in patients with avian influenza virus subtype H7N9 infection.
Haifeng Lu,Chunxia Zhang,Guirong Qian,Xinjun Hu,Hua Zhang,Chunlei Chen,Weifeng Liang,Hainv Gao,Yunmei Yang,Lanjuan Li +9 more
TL;DR: Microbiota restoration treatment reduced the incidence of enterogenous secondary infection, but not exogenous respiratory infection, and the prophylactic effects of microbiota restoration strategies for secondary infection were unsatisfactory in elderly and critically ill patients.
Journal ArticleDOI
Benefit of Early Initiation of Neuraminidase Inhibitor Treatment to Hospitalized Patients With Avian Influenza A(H7N9) Virus
Shufa Zheng,Lingling Tang,Hainv Gao,Yiyin Wang,Fei Yu,Dawei Cui,Guoliang Xie,Xianzhi Yang,Wen Zhang,Xianfei Ye,Zi-Ke Zhang,Xi Wang,Liang Yu,Yiming Zhang,Shigui Yang,Weifeng Liang,Yu Chen,Lanjuan Li +17 more
TL;DR: Early NAI therapy within 2 days of illness shortened the duration of viral shedding and improved survival in patients with H7N9 viral infection.
Journal ArticleDOI
Plasminogen as a prognostic biomarker for HBV-related acute-on-chronic liver failure
Daxian Wu,Sainan Zhang,Zhongyang Xie,Ermei Chen,Qunfang Rao,Xiaoli Liu,Kaizhou Huang,Jing Yang,Lan-Lan Xiao,Feiyang Ji,Zhengyi Jiang,Yalei Zhao,Xiaoxi Ouyang,Danhua Zhu,Xiahong Dai,Zhouhua Hou,Bingjie Liu,Binbin Deng,Ning Zhou,Hainv Gao,Zeyu Sun,Lanjuan Li +21 more
TL;DR: Plasminogen is a promising prognostic biomarker for HBV-ACLF, and sequential plAsminogen measurements could profile the clinical course of HBVs, and P5 is a high-performance prognostic score for HBVs.